Sudden death accounts for a significant proportion of all death in patients with heart failure. Of currently available therapy, amiodarone and the implantable defibrillator (ICD) appear to have the greatest potential to reduce sudden death in heart failure. In this paper, the currently available information on the relative role of amiodarone and implantable defibrillators (ICD) in heart failure is reviewed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s003920050586 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!